This content is from:APP亚博娱乐
Hellman & Friedman, Carlyle To Buy PPD
Affiliates of The Carlyle Group and Hellman & Friedman will acquire Pharmaceutical Product Development.
Affiliates ofThe Carlyle GroupandHellman & Friedmanwill acquire制药Product Development(PPD). The deal is estimated to fetch PPD $3.9 billion. The all-cash transaction has fully committed financing, comprising a blend of equity made available byCarlyle Partners VandHellman & Friedman Capital Partners VII, and external debt financing byCredit Suisse,J.P. Morgan,Goldman Sachs GroupandUBS.
As part of the acquisition, Carlyle and Hellman & Friedman will buy the outstanding common shares of PPD by paying $33.25 per unit in cash.Morgan Stanley & Co.is financial adviser to PPD and Credit Suisse to Carlyle and Hellman & Friedman.
Click here for the release fromBusiness Wire.